|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| A61P 35/00 | (2006.01) | ||
| A61K 9/19 | (2006.01) |
| (11) | Number of the document | 2968588 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14722450.5 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-09 |
| (46) | Date of publication of the claims translation | 2019-05-10 |
| (86) | Number | PCT/US2014/027868 |
| Date | 2014-03-14 |
| (87) | Number | WO 2014/143765 |
| Date | 2014-09-18 |
| (30) | Number | Date | Country code |
| 201361790490 P | 2013-03-15 | US |
| (72) |
TSCHOEPE, Markus, DE
KALETA, Katharina, DE
KUMAR, Vineet, US
|
| (73) |
AbbVie Inc.,
1 North Waukegan Road, North Chicago, IL 60064,
US
Abbvie Deutschland GmbH & Co. KG, Max-Planck-Ring 2a, 65205 Wiesbaden, DE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Anti-EGFR antikūnų vaistų konjugatų kompozicijos |
| ANTI-EGFR ANTIBODY DRUG CONJUGATE FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2023-03-02 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-03-14 |